quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:05:15·150d
INSIDERFiling
Standard BioTools Inc. logo

President & CEO Egholm Michael covered exercise/tax liability with 63,529 shares, decreasing direct ownership by 1% to 5,617,837 units (SEC Form 4)

LAB· Standard BioTools Inc.
Industrials
Original source

Companies

  • LAB
    Standard BioTools Inc.
    Industrials

Recent analyst ratings

  • Aug 13UpdateTD Cowen$1.55
  • Feb 27UpdateKeyBanc Capital Markets-
  • Apr 16UpdateTD Cowen$3.50
  • Apr 4UpdateJefferies$3.25
  • Jul 12UpdateKeyBanc Capital Markets$4.00

Related

  • PR3d
    Standard BioTools to Announce First Quarter 2026 Financial Results on May 5, 2026
  • INSIDER15d
    SEC Form 4 filed by Egholm Michael
  • INSIDER15d
    SEC Form 4 filed by Kim Hanjoon Alex
  • INSIDER15d
    SEC Form 4 filed by Mackay Sean
  • SEC38d
    SEC Form 10-K filed by Standard BioTools Inc.
  • INSIDER52d
    Director Casdin Eli was granted 52,991 shares, increasing direct ownership by 2% to 2,954,053 units (SEC Form 4)
  • INSIDER52d
    Director Cox Troy was granted 57,264 shares, increasing direct ownership by 18% to 376,586 units (SEC Form 4)
  • INSIDER52d
    Director Carey Thomas D. was granted 51,282 shares, increasing direct ownership by 26% to 245,340 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022